Press "Enter" to skip to content

Posts tagged as “AD”

Biogen Stays the Wrong Course After a Key Drug Failure

"Biogen is by far the worst-performing large-cap biotech stock of 2019 after the March failure of its key Alzheimer’s drug pushed its shares down more than 20 percent. Its first-quarter earnings results announced on Wednesday, while beating analysts’ profit estimates, did little to turn things around. A much-needed strategic shift was missing."

Failure of once-promising Alzheimer’s drug reinforces doubts about amyloid beta | Med City News


"It had made its way into two Phase III trials thanks to Phase Ib data demonstrating its efficacy at reducing plaques of the peptide amyloid beta — a defining feature of Alzheimer’s disease — with observable clinical benefit to boot. But last month, Biogen and its partner, Japan’s Eisai, shocked the world by halting the Phase III studies, ENGAGE and EMERGE , after a futility analysis by the program’s independent data monitoring committee showed the trials were likely to fail."

Former NFL Wife on Her Husband’s Battle with CTE

"Former NFL wife and author of “After the Cheering Stops,” Cyndy Feasel discusses CTE, sports’ injuries and what parents should know about the impact of head injuries on their children."

Early Detection of Alzheimer’s Prior to Onset of Symptoms Now Possible | Science Times


"Oxford Brain Diagnostics believe that their technology can catch the condition years before symptoms become apparent. Oxford Brain Diagnostics (OBD) is the result of an 8-year collaboration between Professor Steven Chance (neuroscience and pathology) and Professor Mark Jenkinson (brain imaging). They have developed a new method that directly measures the cellular health of patients' brain circuits from standard MRI data. "

We Need New Ideas for Fighting Alzheimer’s | Scientific American


"The Alzheimer’s Association estimates that more than 5.8 million Americans have Alzheimer’s disease, a number that will double by 2040 and cost $1 trillion per year by 2050. Currently, there are no therapies to prevent or stop the progression of Alzheimer’s once it develops. This dire situation needs a solution."